Effect of Parathyroidectomy on Metabolic Homeostasis in Primary Hyperparathyroidism.
PCSK9
cardiovascular risk factors
diabetes
dyslipidemia
insulin resistance
parathyroidectomy
primary hyperparathyroidism
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
02 Mar 2022
02 Mar 2022
Historique:
received:
13
01
2022
revised:
20
02
2022
accepted:
28
02
2022
entrez:
10
3
2022
pubmed:
11
3
2022
medline:
11
3
2022
Statut:
epublish
Résumé
Background: The benefits of parathyroidectomy on cardiovascular risk in primary hyperparathyroidism (PHPT) are controversial. This monocentric, observational, prospective study aimed to assess the effects of parathyroidectomy on glucose and lipid metabolism in classic or mild PHPT. Methods: Patients who underwent parathyroidectomy for classic (calcemia >2.85 mmol/L) or mild PHPT (calcemia ≤2.85 mmol/L) between 2016 and 2019 were included. A metabolic assessment was performed before and 1 year after parathyroidectomy. Patients with a history of diabetes were excluded. Results: Nineteen patients had classic and 120 had mild PHPT. Ninety-five percent were normocalcemic 6 months after surgery. Fasting plasma glucose and insulin levels decreased after parathyroidectomy in patients with mild PHPT (p < 0.001). HOMA-IR decreased after surgery in the overall population (p < 0.001), while plasma adiponectin concentrations increased in patients with both classic (p = 0.005) and mild PHPT (p < 0.001). Plasma triglyceride levels decreased significantly only in patients with classic PHPT (p = 0.021). Plasma PCSK9 levels decreased in patients with mild PHPT (p < 0.001). Conclusions: Parathyroidectomy for PHPT improves insulin resistance and decreases plasma triglyceride levels in classic PHPT and plasma PCSK9 levels in mild PHPT. Further studies are needed to better characterize the consequences of such metabolic risk factors’ improvements on cardiovascular events.
Identifiants
pubmed: 35268464
pii: jcm11051373
doi: 10.3390/jcm11051373
pmc: PMC8911089
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Appel d'Offre Interne (AOI) of the CHU Nantes.
ID : AOI-CHUN-2015-CO
Références
Hepatology. 2008 Aug;48(2):646-54
pubmed: 18666258
J Clin Med. 2020 Jan 17;9(1):
pubmed: 31963408
Atherosclerosis. 2011 Jun;216(2):258-65
pubmed: 21596380
J Clin Endocrinol Metab. 2011 Jul;96(7):2112-8
pubmed: 21593116
Nutr Metab (Lond). 2013 Jan 08;10(1):4
pubmed: 23298392
J Clin Endocrinol Metab. 2000 Mar;85(3):1054-8
pubmed: 10720039
Metabolism. 2005 Feb;54(2):206-11
pubmed: 15690315
Lancet. 1997 Apr 26;349(9060):1233-8
pubmed: 9130957
J Steroid Biochem Mol Biol. 2017 Jan;165(Pt B):369-381
pubmed: 27520301
Atherosclerosis. 2016 May;248:62-75
pubmed: 26987067
Am J Physiol Renal Physiol. 2001 Feb;280(2):F291-302
pubmed: 11208605
Clin Endocrinol (Oxf). 2002 Feb;56(2):253-60
pubmed: 11874418
Endocr Connect. 2018 Aug 01;7(8):941-948
pubmed: 30300532
Int J Endocrinol. 2011;2011:309068
pubmed: 21403888
Clin Endocrinol (Oxf). 2011 Aug;75(2):169-76
pubmed: 21158894
Int J Mol Sci. 2019 Mar 08;20(5):
pubmed: 30857216
Diabetes Metab Res Rev. 2007 Jan;23(1):43-8
pubmed: 16703622
Clin Endocrinol (Oxf). 2013 Jul;79(1):27-34
pubmed: 23506565
Biochem Med (Zagreb). 2011;21(3):312-20
pubmed: 22420246
Clin Endocrinol (Oxf). 2010 Jul;73(1):30-4
pubmed: 20039887
Atherosclerosis. 2011 Nov;219(1):342-8
pubmed: 21889145
Indian J Surg. 2017 Apr;79(2):101-105
pubmed: 28442834
Am Heart J. 2011 Aug;162(2):331-339.e2
pubmed: 21835295
N Engl J Med. 2006 Mar 23;354(12):1264-72
pubmed: 16554528
Diabetes. 2002 Jun;51(6):1884-8
pubmed: 12031977
BMC Cardiovasc Disord. 2019 May 8;19(1):106
pubmed: 31068134
Oncologist. 2014 Sep;19(9):919-29
pubmed: 25063228
Am J Physiol Endocrinol Metab. 2001 Mar;280(3):E405-12
pubmed: 11171594
Scand J Clin Lab Invest. 2012 Apr;72(2):92-9
pubmed: 22106852
J Clin Endocrinol Metab. 1982 Aug;55(2):303-6
pubmed: 7085856
World J Surg. 2003 Feb;27(2):216-22
pubmed: 12616440
Curr Opin Clin Nutr Metab Care. 2017 May;20(3):153-157
pubmed: 28257332
J Clin Endocrinol Metab. 2006 Feb;91(2):629-34
pubmed: 16317057
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3223-3232
pubmed: 30860588
Bone. 2015 May;74:121-4
pubmed: 25637062
Endocrine. 2017 Jan;55(1):283-288
pubmed: 27844209
N Engl J Med. 2018 Nov 29;379(22):2097-2107
pubmed: 30403574
Diabetes Metab Res Rev. 2016 Feb;32(2):193-9
pubmed: 26377225
Indian J Endocrinol Metab. 2016 Nov-Dec;20(6):784-789
pubmed: 27867880
Endocrine. 2021 Apr;72(1):72-85
pubmed: 33057988
N Engl J Med. 2017 May 4;376(18):1713-1722
pubmed: 28304224
Circulation. 2016 Mar 29;133(13):1230-9
pubmed: 26896437
Langenbecks Arch Surg. 2019 Jun;404(4):431-438
pubmed: 30955085
FEBS Lett. 2008 Mar 19;582(6):949-55
pubmed: 18298956
J Clin Endocrinol Metab. 2009 Jul;94(7):2255-61
pubmed: 19351725
Langenbecks Arch Surg. 2010 Sep;395(7):941-6
pubmed: 20658300
J Clin Endocrinol Metab. 2014 Oct;99(10):3561-9
pubmed: 25162665
Nutr Metab Cardiovasc Dis. 2021 Apr 9;31(4):981-996
pubmed: 33612382
Eur J Endocrinol. 2013 Oct 21;169(6):795-804
pubmed: 24026893
Biol Trace Elem Res. 2013 Jun;153(1-3):35-40
pubmed: 23539147
Arch Biochem Biophys. 2016 Oct 1;607:47-54
pubmed: 27565442
Clin Chim Acta. 2014 Feb 15;429:147-51
pubmed: 24362231
Br J Surg. 2018 Feb;105(3):223-229
pubmed: 29405278
J Surg Res. 2020 Jan;245:22-30
pubmed: 31400574
Medicine (Baltimore). 2016 Feb;95(8):e2774
pubmed: 26937904
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Clin Endocrinol (Oxf). 2019 Jan;90(1):184-191
pubmed: 30267589
Basic Res Cardiol. 2017 May;112(3):32
pubmed: 28439730
Nutrients. 2020 Nov 16;12(11):
pubmed: 33207657